This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
050 Canadian Provider Perspectives on Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease and the Impact of its Discontinuation. (1st March 2021)
Record Type:
Journal Article
Title:
050 Canadian Provider Perspectives on Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease and the Impact of its Discontinuation. (1st March 2021)
Main Title:
050 Canadian Provider Perspectives on Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease and the Impact of its Discontinuation